Triple
T21289788
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Paul Schimmel |
E524754
|
entity |
| Predicate | coFounded |
P104
|
FINISHED |
| Object | Repligen |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Repligen | Statement: [Paul Schimmel, coFounded, Repligen]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Repligen Context triple: [Paul Schimmel, coFounded, Repligen]
-
A.
Hargreave-Rasch Biotechnologies
Hargreave-Rasch Biotechnologies is a fictional advanced biotech corporation in the Crysis video game universe, known for its cutting-edge research into alien technology and military applications.
-
B.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
-
C.
Lonza
Lonza is a river in the Swiss canton of Valais that flows through the Lötschental valley before joining the Rhône.
-
D.
Horizon Discovery
Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
-
E.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Repligen Target entity description: Repligen is a biotechnology company known for developing and supplying bioprocessing technologies and materials used in the manufacture of biologic drugs.
-
A.
Hargreave-Rasch Biotechnologies
Hargreave-Rasch Biotechnologies is a fictional advanced biotech corporation in the Crysis video game universe, known for its cutting-edge research into alien technology and military applications.
-
B.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
-
C.
Lonza
Lonza is a river in the Swiss canton of Valais that flows through the Lötschental valley before joining the Rhône.
-
D.
Horizon Discovery
Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
-
E.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e0b5171f6c8190a5d57201ede73811 |
completed | April 16, 2026, 10:08 a.m. |
| NER | Named-entity recognition | batch_69e736d9467881908ec5b1dec76e6f5d |
completed | April 21, 2026, 8:35 a.m. |
Created at: April 16, 2026, 4:03 p.m.